Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Fatigue 5Breast Neoplasms 5Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Depression 2Congenital Abnormalities 2Carcinoma, Ovarian Epithelial 2Vomiting 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Sexuality 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Nausea 1Myeloproliferative Disorders 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Biopsy 2pertuzumab 1Vaccines 1Trastuzumab 1Therapeutics 1Risedronic Acid 1Mastectomy, Simple 1Mastectomy, Segmental 1Mammaplasty 1Ferric Oxide, Saccharated 1Cryosurgery 1Cholecalciferol 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Intraductal, Noninfiltrating × Therapeutics × Clear all
NCT02168179 2018-07-05

KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer

Wake Forest University Health Sciences

Phase NA Withdrawn
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡